Evidence map›Paper›PMID 16799880›Full record

ReviewJournal of gastroenterology2006

DNA methylation as a marker for the past and future.

Toshikazu Ushijima, Takeshi Nakajima, Takao Maekita

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Journal of gastroenterology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04031716 (Genetic, Epigenetic, Psychosocial, and Biological Determinants of Post-surgical Pain After Pectus or Spine Surgery), which is not on this map. Cited by 56 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 5 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04031716 naactive not recruitingnot on this mapstarted 2018, after this paper: background citation

Genetic, Epigenetic, Psychosocial, and Biological Determinants of Post-surgical Pain After Pectus or Spine Surgery

TypeinterventionalSponsorChildren's Hospital Medical Center, CincinnatiRan2018 to 2025Enrolled600ConditionsPain, Postoperative, Excavatum, Pectus, Scoliosis IdiopathicArmsMeditation
3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 5 syntheses or guidelines pooled it, 149 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Review
  7. Article
  8. Article
  9. Article
  10. FGFR3Cell death & disease · 2020
    Article
  11. Article
  12. Review
  13. Article
  14. Observational
  15. Article
  16. Pathogens (Basel, Switzerland) · 2019
    Review
  17. Aberrant methylation ofJournal of Cancer · 2018
    Article
  18. Aberrant DNA methylation of theJournal of Cancer · 2018
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Toshikazu UshijimaCarcinogenesis Division, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan.
Takeshi Nakajima
Takao Maekita
Genesis Research Institute · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aberrant methylation of CpG islands in promoter regions can permanently inactivate tumor-suppressor genes, as mutations and chromosomal abnormalities do. In gastric cancers, CDKN2A, CDH1, and MLH1 are inactivated more frequently by aberrant methylation than by mutations, and novel tumor-suppressor genes inactivated by promoter methylation are being identified. We recently found that Helicobacter pylori (HP), a potent gastric carcinogen, induces aberrant methylation in gastric mucosae. When a panel of CpG islands was examined, some CpG islands were consistently methylated in gastric mucosae of individuals with HP infection, while others were resistant. The amount of methylated DNA molecules in the gastric mucosae (methylation level) fluctuated while active HP infection was present, but decreased after it was no longer present. Among individuals without active HP infection, methylation levels in the gastric mucosae were higher in individuals with gastric cancers than in those without. DNA methylation is emerging as a promising marker for past exposure to carcinogens and future risk of cancers.

Indexed as

DNA MethylationCadherinsGastric MucosaGenes, p16Genes, Tumor SuppressorGenetic MarkersHelicobacter pyloriHumansRiskStomach NeoplasmsCadherinsGenetic Markers

Identifiers

PMID16799880
OpenAlexW2077632975

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.